HHS.gov

The file is provided for reference purposes only. It was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance. Please select hhs.gov to access current information.

 

Vaccine Research



The National Vaccine Program Office funds vaccine and immunization research projects to Federal agency partners.  These funds provide short term support for high priority areas outlined in the National Vaccine Plan.

NVPO Unmet Needs

In addition to the NVPO supported research, several DHHS agencies support vaccine research. 

NIH

Because vaccines can provide a safe, effective and efficient means to prevent illness, disability and death from infectious diseases, research leading to new and improved vaccines is a high priority for NIH .  See Medline Plus for additional information about  vaccine research supported by NIH.  See the National Institute for Infectious Diseases (NIAID), The Vaccine Research Center (VRC), the National Institute on Aging, and the National Institute for Child and Human Development (NICHD) for specific, disease-related vaccine information.

CDC

The National Immunization Program, CDC supports research to better understand the potential long-term effects of vaccinations and to understand how to better communicate the potential risks and benefits of vaccines to the public.  Vaccine safety data is collected through the Vaccine Adverse Events Reporting System, which is co-funded by the FDA.

FDA

A wide variety of changing technical and scientific issues related to the safety, potency, and efficacy of novel biological products requires knowledge of new developments and concepts of basic research in the relevant biological disciplines.  The Center for Biologics Evaluation and Research, FDA supports research to better understand fundamental biological processes and provides a strong scientific base for regulatory review.

AHRQ

AHRQ's research projects examine the availability, quality, and costs of health care services; and ways to improve the effectiveness and appropriateness of clinical practice, including the prevention of disease.

Last revised: May 22, 2006

spacer

HHS Home | Questions? | Contact HHS | Accessibility | Privacy Policy | FOIA | Disclaimers

The White House | USA.gov | Helping America's Youth